Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
-
Janux Therapeutics (JANX) Announces Proposed $300M Share Offering
-
Janux Therapeutics Announces Proposed Public Offering
-
Janux Therapeutics (JANX) PT Raised to $200 at Cantor Fitzgerald, 'Mic Drop - '007 HRPC Update Waaayyy Above Expectations'
-
Janux Therapeutics (JANX) Prices $296.5M Share and Warrant Offering at $46.50/sh
-
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
-
Janux Therapeutics (JANX) Announces Proposed $175M Share Offering
-
Janux Therapeutics Announces Proposed Public Offering of Common Stock
